ArticleFrontiers in neurology2025
Evaluation of the therapeutic effect of adaptive deep brain stimulation on motor symptoms and sleep disturbances in Parkinson's disease and construction of a response prediction model.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Parkinson's disease patients often experience symptoms such as motor impairments and sleep disturbances. This study aims to evaluate the efficacy of adaptive deep brain stimulation therapy in improving motor symptoms and sleep disorders in patients with Parkinson's disease. Methods: This retrospective cohort study included 280 patients with Parkinson's disease. Baseline data were analyzed to assess changes in motor symptoms and sleep disorders before and after treatment. Factors influencing treatment efficacy were explored using univariate and multivariate logistic regression analyses, based on which a response prediction model was constructed. A generalized linear mixed model was then employed to examine interactions between the response model and other variables. Results: After treatment, the Unified Parkinson's Disease Rating Scale Part II (UPDRS II), Unified Parkinson's Disease Rating Scale Part III (UPDRS III), Parkinson's Disease Sleep Scale (PDSS), Pittsburgh Sleep Quality Index (PSQI), and Epworth Sleepiness Scale (ESS) scores in the observation group (adaptive deep brain stimulation, aDBS) were significantly lower than those in the control group, indicating better motor and non-motor symptom control. In contrast, the Mini-Mental State Examination (MMSE) score was significantly higher in the observation group, suggesting improved cognitive function. Age, body mass index (BMI), disease duration, Hoehn and Yahr stage, smoking history, and baseline neutrophil-to-lymphocyte ratio (NLR) were negatively associated with symptom improvement. In contrast, adaptive deep brain stimulation (aDBS) treatment showed a significant positive association with symptom improvement. The predictive model constructed based on blood biomarkers, demographic factors, and treatment response demonstrated good predictive performance for clinical improvement. Furthermore, generalized linear mixed model (GLMM) analysis revealed that the response model exerted an antagonistic effect on BMI and high-density lipoprotein (HDL) levels, and a synergistic effect on the platelet-to-lymphocyte ratio (PLR). Conclusion: The effectiveness of adaptive deep brain stimulation (aDBS) therapy in improving motor symptoms, sleep disorders, and quality of life in patients with Parkinson's disease is superior to that of conventional treatment. Factors such as patient age, body mass index (BMI), disease duration, Hoehn-Yahr stage, and baseline blood marker levels can influence the efficacy of aDBS. The constructed response model effectively predicts symptom improvement and offers valuable guidance for clinical treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.